目標(biāo)和范圍總編:蘇雷什·安東尼教授《感染與耐藥性》是一份國(guó)際、同行評(píng)議的開(kāi)放獲取期刊，重點(diǎn)關(guān)注感染(細(xì)菌、真菌和病毒)的最佳治療，以及制定和制定預(yù)防策略，以最大限度地減少耐藥性的發(fā)展和傳播。該雜志特別關(guān)注抗生素耐藥性的流行病學(xué)以及耐藥性在醫(yī)院和社區(qū)的發(fā)展和擴(kuò)散機(jī)制。特別是，研究和臨床開(kāi)發(fā)新的抗感染作用機(jī)制和現(xiàn)有治療方法的最佳使用將受到重視。其他領(lǐng)域包括感染的診斷和早期檢測(cè)，蛋白質(zhì)組學(xué)和基因組學(xué)研究，以確定耐藥生物體表面蛋白的特征，以及教育和感染控制策略。隨著與產(chǎn)生耐藥性相關(guān)的死亡率、發(fā)病率和醫(yī)療成本的增加，旨在改善結(jié)果和患者依從性和滿(mǎn)意度的研究、臨床研究和規(guī)劃將得到優(yōu)先考慮。該雜志的特點(diǎn)是快速報(bào)告的審查，指南，原始研究和臨床研究的所有領(lǐng)域的感染和耐藥性。

Aims and ScopeEditor-in-Chief: Professor Suresh AntonyInfection and Drug Resistance is an international, peer-reviewed, open access journal that focuses on the optimal treatment of infection (bacterial, fungal and viral) and the development and institution of preventative strategies to minimize the development and spread of resistance. The journal is specifically concerned with the epidemiology of antibiotic resistance and the mechanisms of resistance development and diffusion in both hospitals and the community. In particular, research and clinical development of novel mechanism of action anti-infectives and the optimal use of existing therapies will be highlighted. Other areas of coverage include diagnostic and early detection of infection, proteomic and genomic studies to characterize surface proteins in resistant organisms, and educational and infection control strategies. With increased mortality, morbidity and healthcare costs associated with developing resistance, research, clinical studies and programs designed to improve outcomes and patient adherence and satisfaction will be given priority. The journal is characterized by the rapid reporting of reviews, guidelines, original research and clinical studies in all areas of infection and drug resistance.